Todd Harris
Fondatore presso TYRA BIOSCIENCES, INC.
Patrimonio netto: 24 M $ in data 30/06/2024
Profilo
Todd J.
Harris is the founder of Tyra Biosciences, Inc., which was founded in 2018.
He holds the title of President, CEO, Treasurer & Director at Tyra Biosciences, Inc. Dr. Harris is also the founder of Sienna Biopharmaceuticals, Inc., which was founded in 2010.
At Sienna Biopharmaceuticals, Inc., he held the title of Director & Head-Corporate Development from 2016 to 2018.
Currently, Dr. Harris is the Director at Primmune Therapeutics, Inc., a position he has held since 2019.
Dr. Harris obtained a doctorate degree from the Massachusetts Institute of Technology.
He also holds an undergraduate degree from Brigham Young University and a graduate degree from the University of California San Diego.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
TYRA BIOSCIENCE, INC
2.86% | 26/03/2024 | 1 504 577 ( 2.86% ) | 24 M $ | 30/06/2024 |
Posizioni attive di Todd Harris
| Società | Posizione | Inizio |
|---|---|---|
| TYRA BIOSCIENCES, INC. | Fondatore | 02/08/2018 |
Primmune Therapeutics, Inc.
 Primmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Primmune Therapeutics, Inc. develops small molecules, orally administered toll-like receptor for cancer immunotherapy and tumors. The firm offers treatment and prevention of viral infections. The company was founded by Paulo Rangel, James Appleman, and Stephen Webber in October, 2017 and is headquartered in San Diego, CA. | Direttore/Membro del Consiglio | 01/10/2019 |
Precedenti posizioni note di Todd Harris
| Società | Posizione | Fine |
|---|---|---|
| SIENNA BIOPHARMACEUTICALS, INC. | Fondatore | 01/07/2018 |
Formazione di Todd Harris
| Brigham Young University | Undergraduate Degree |
| University of California San Diego | Graduate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SIENNA BIOPHARMACEUTICALS, INC. | Health Technology |
| TYRA BIOSCIENCES, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Primmune Therapeutics, Inc.
Primmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Primmune Therapeutics, Inc. develops small molecules, orally administered toll-like receptor for cancer immunotherapy and tumors. The firm offers treatment and prevention of viral infections. The company was founded by Paulo Rangel, James Appleman, and Stephen Webber in October, 2017 and is headquartered in San Diego, CA. | Commercial Services |
- Borsa valori
- Insiders
- Todd Harris
